Understanding the Feasibility of a Co-designed Pre-radiotherapy Exercise Programme - A Single-arm Study
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this clinical trial is to understand the feasibility of a co-designed, pre-radiotherapy exercise programme for people with stage I-III non-small cell lung cancer. This involves people with lung cancer engaging in 20 minutes exercises sessions performed within the radiotherapy department and immediately before each treatment at a personalised intensity. The main questions it aims to answer are: To understand the acceptability of the exercise programme through monitoring recruitment rates, attendance of the exercise sessions, and adherence to prescribed exercise intensities. Adverse events will also be monitored to understand programme safety. Follow-up qualitative interviews will be conducted with participants, their family members, and health care professionals (HCP) to further explore the acceptability of the exercise programme. In total, participants will be invited to perform up to twenty, supervised exercise sessions scheduled immediately before each treatment within the radiotherapy department. Each exercise session will be twenty minutes in duration and will be performed on a stationary exercise bike. Regarding exercise intensity, there are four levels which may be prescribed depending on people's exercise history, baseline exercise experience, and personal preference. Participants may progress or regress exercise intensity levels throughout the programme depending on their adherence and preference.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony rak płuca w stopniu 1-3
- •Planowana radioterapia jako główne leczenie
- •Wiek co najmniej 18 lat
- •Potwierdzenie przez lekarza, że pacjent może bezpiecznie ćwiczyć
- •Możliwość komunikacji w języku angielskim
- •Pisemna zgoda na udział w badaniu
✗ Disqualifies
- •Świeża dławica piersiowa lub niestabilna choroba serca (ostatni miesiąc)
- •Niestabilna lub ostra niewydolność serca (ostatnie 3 miesiące)
- •Nowe lub niekontrolowane zaburzenia rytmu serca
- •Podejrzenie ucisku rdzenia kręgowego
- •Niekontrolowana cukrzyca
- •Jednoczesne leczenie chemioterapią lub immunoterapią
- •Ból w klatce piersiowej podczas ćwiczeń
- •Ciąża
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 8, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Northern Ireland Cancer Centre, City Hospital, BHSCT
Belfast, United Kingdom
Trial contact
Matthew Peter Beggs, MSc, BSc
Gillian Dr Prue, PhD., HCPC, FHEA, MCSP
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/9/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.